386 related articles for article (PubMed ID: 18180305)
1. A novel role of vascular endothelial cadherin in modulating c-Src activation and downstream signaling of vascular endothelial growth factor.
Ha CH; Bennett AM; Jin ZG
J Biol Chem; 2008 Mar; 283(11):7261-70. PubMed ID: 18180305
[TBL] [Abstract][Full Text] [Related]
2. Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers.
Adam AP; Sharenko AL; Pumiglia K; Vincent PA
J Biol Chem; 2010 Mar; 285(10):7045-55. PubMed ID: 20048167
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation.
Lin MT; Yen ML; Lin CY; Kuo ML
Mol Pharmacol; 2003 Nov; 64(5):1029-36. PubMed ID: 14573751
[TBL] [Abstract][Full Text] [Related]
4. eNOS-derived nitric oxide regulates endothelial barrier function through VE-cadherin and Rho GTPases.
Di Lorenzo A; Lin MI; Murata T; Landskroner-Eiger S; Schleicher M; Kothiya M; Iwakiri Y; Yu J; Huang PL; Sessa WC
J Cell Sci; 2013 Dec; 126(Pt 24):5541-52. PubMed ID: 24046447
[TBL] [Abstract][Full Text] [Related]
5. The tyrosine phosphatase SHP2 regulates recovery of endothelial adherens junctions through control of β-catenin phosphorylation.
Timmerman I; Hoogenboezem M; Bennett AM; Geerts D; Hordijk PL; van Buul JD
Mol Biol Cell; 2012 Nov; 23(21):4212-25. PubMed ID: 22956765
[TBL] [Abstract][Full Text] [Related]
6. VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd.
Sun Z; Li X; Massena S; Kutschera S; Padhan N; Gualandi L; Sundvold-Gjerstad V; Gustafsson K; Choy WW; Zang G; Quach M; Jansson L; Phillipson M; Abid MR; Spurkland A; Claesson-Welsh L
J Exp Med; 2012 Jul; 209(7):1363-77. PubMed ID: 22689825
[TBL] [Abstract][Full Text] [Related]
7. Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site.
Wallez Y; Cand F; Cruzalegui F; Wernstedt C; Souchelnytskyi S; Vilgrain I; Huber P
Oncogene; 2007 Feb; 26(7):1067-77. PubMed ID: 16909109
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway.
Liu D; Xu H; Zhang C; Xie H; Yang Q; Li W; Tian H; Lu L; Xu JY; Xu G; Liu K; Sun X; Xu GT; Zhang J
Life Sci; 2020 Oct; 259():118273. PubMed ID: 32800831
[TBL] [Abstract][Full Text] [Related]
9. Association of Csk to VE-cadherin and inhibition of cell proliferation.
Baumeister U; Funke R; Ebnet K; Vorschmitt H; Koch S; Vestweber D
EMBO J; 2005 May; 24(9):1686-95. PubMed ID: 15861137
[TBL] [Abstract][Full Text] [Related]
10. SHP2 protects endothelial cell barrier through suppressing VE-cadherin internalization regulated by MET-ARF1.
Zhang J; Huang J; Qi T; Huang Y; Lu Y; Zhan T; Gong H; Zhu Z; Shi Y; Zhou J; Yu L; Zhang X; Cheng H; Ke Y
FASEB J; 2019 Jan; 33(1):1124-1137. PubMed ID: 30102570
[TBL] [Abstract][Full Text] [Related]
11. Roles of Gab1 and SHP2 in paxillin tyrosine dephosphorylation and Src activation in response to epidermal growth factor.
Ren Y; Meng S; Mei L; Zhao ZJ; Jove R; Wu J
J Biol Chem; 2004 Feb; 279(9):8497-505. PubMed ID: 14665621
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor signaling potentiates VE-cadherin stability at adherens junctions by regulating SHP2.
Hatanaka K; Lanahan AA; Murakami M; Simons M
PLoS One; 2012; 7(5):e37600. PubMed ID: 22629427
[TBL] [Abstract][Full Text] [Related]
13. Endothelial cell SHP-2 negatively regulates neutrophil adhesion and promotes transmigration by enhancing ICAM-1-VE-cadherin interaction.
Yan M; Zhang X; Chen A; Gu W; Liu J; Ren X; Zhang J; Wu X; Place AT; Minshall RD; Liu G
FASEB J; 2017 Nov; 31(11):4759-4769. PubMed ID: 28701303
[TBL] [Abstract][Full Text] [Related]
14. New role for the protein tyrosine phosphatase DEP-1 in Akt activation and endothelial cell survival.
Chabot C; Spring K; Gratton JP; Elchebly M; Royal I
Mol Cell Biol; 2009 Jan; 29(1):241-53. PubMed ID: 18936167
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine phosphorylation of DEP-1/CD148 as a mechanism controlling Src kinase activation, endothelial cell permeability, invasion, and capillary formation.
Spring K; Chabot C; Langlois S; Lapointe L; Trinh NT; Caron C; Hebda JK; Gavard J; Elchebly M; Royal I
Blood; 2012 Sep; 120(13):2745-56. PubMed ID: 22898603
[TBL] [Abstract][Full Text] [Related]
16. Role of protein tyrosine phosphatase 1B in vascular endothelial growth factor signaling and cell-cell adhesions in endothelial cells.
Nakamura Y; Patrushev N; Inomata H; Mehta D; Urao N; Kim HW; Razvi M; Kini V; Mahadev K; Goldstein BJ; McKinney R; Fukai T; Ushio-Fukai M
Circ Res; 2008 May; 102(10):1182-91. PubMed ID: 18451337
[TBL] [Abstract][Full Text] [Related]
17. Aberrant association between vascular endothelial growth factor receptor-2 and VE-cadherin in response to vascular endothelial growth factor-a in Shb-deficient lung endothelial cells.
Zang G; Christoffersson G; Tian G; Harun-Or-Rashid M; Vågesjö E; Phillipson M; Barg S; Tengholm A; Welsh M
Cell Signal; 2013 Jan; 25(1):85-92. PubMed ID: 23000345
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial-cadherin tyrosine phosphorylation in angiogenic and quiescent adult tissues.
Lambeng N; Wallez Y; Rampon C; Cand F; Christé G; Gulino-Debrac D; Vilgrain I; Huber P
Circ Res; 2005 Feb; 96(3):384-91. PubMed ID: 15662029
[TBL] [Abstract][Full Text] [Related]
19. eNOS-induced vascular barrier disruption in retinopathy by c-Src activation and tyrosine phosphorylation of VE-cadherin.
Ninchoji T; Love DT; Smith RO; Hedlund M; Vestweber D; Sessa WC; Claesson-Welsh L
Elife; 2021 Apr; 10():. PubMed ID: 33908348
[TBL] [Abstract][Full Text] [Related]
20. Pyk2 phosphorylation of VE-PTP downstream of STIM1-induced Ca
Soni D; Regmi SC; Wang DM; DebRoy A; Zhao YY; Vogel SM; Malik AB; Tiruppathi C
Am J Physiol Lung Cell Mol Physiol; 2017 Jun; 312(6):L1003-L1017. PubMed ID: 28385807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
